ITRI

Itron, Inc. NASDAQ

Technology ·Hardware, Equipment & Parts ·US · itron.com/na

$84.22

After hrs $84.42 +0.00%

Mkt Cap $3.7B

52w Low $78.53 9.0% of range 52w High $142.00

50d MA $92.05 200d MA $107.49

P/E (TTM) 12.9x

EV/EBITDA 11.7x

P/B 2.2x

Debt/Equity 0.8x

ROE 18.0%

P/FCF 11.0x

RSI (14) —

ATR (14) —

Beta 1.50

50d MA $92.05

200d MA $107.49

Avg Volume 1.1M

About

Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing. The Networked Solutions segment provi…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 28, 2026	BMO	1.26	1.49	+18.3%	86.92	-0.8%	+0.1%	-4.9%	-3.6%	-1.7%	-3.1%	—
Feb 17, 2026	BMO	2.19	2.46	+12.3%	89.36	+10.7%	+7.9%	+11.4%	+10.9%	+11.4%	+6.5%	—
Oct 30, 2025	BMO	1.48	1.54	+4.1%	138.18	-1.4%	-21.1%	-27.4%	-22.7%	-22.9%	-22.5%	—
Jul 31, 2025	BMO	1.33	1.62	+21.8%	138.42	-5.6%	-10.0%	-11.0%	-9.2%	-10.6%	-9.5%	—
May 1, 2025	BMO	1.30	1.52	+16.9%	111.29	-2.8%	-2.9%	-2.7%	-3.4%	-4.1%	-4.5%	—
Feb 25, 2025	BMO	1.05	1.35	+28.6%	92.60	+10.7%	+9.9%	+16.3%	+15.4%	+17.6%	+15.0%	—
Oct 31, 2024	BMO	1.13	1.84	+62.8%	103.86	+6.2%	+7.6%	+7.7%	+10.7%	+13.3%	+17.6%	—
Aug 1, 2024	BMO	0.96	1.21	+26.0%	103.44	+2.7%	+4.5%	-2.2%	-5.8%	-5.5%	-8.0%	—
May 2, 2024	BMO	0.84	1.24	+47.6%	91.54	+6.0%	+9.0%	+16.9%	+17.3%	+18.3%	+19.1%	—
Feb 26, 2024	BMO	0.75	1.23	+64.0%	74.93	+24.6%	+22.1%	+21.5%	+25.7%	+23.7%	+24.4%	—
Nov 2, 2023	BMO	0.51	0.98	+92.2%	56.85	+9.7%	+12.8%	+13.1%	+14.3%	+11.4%	+13.0%	—
Aug 3, 2023	BMO	0.31	0.65	+109.7%	76.75	+2.9%	-0.2%	-6.4%	-10.0%	-10.1%	-10.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 29	TD Cowen	Maintains	Buy → Buy	—	$87.00	$85.77	-1.4%	-5.0%	-3.7%	-1.8%	—	—
Apr 29	TD Cowen	Reiterates	Buy	$130	$87.00	$85.77	-1.4%	-5.0%	-3.7%	-1.8%	—	—
Apr 21	Raymond James	Initiates	Underperform	—	$97.63	$96.03	-1.6%	-3.6%	-8.1%	-9.3%	-9.3%	-11.0%
Apr 16	JP Morgan	Maintains	Overweight → Overweight	—	$97.55	$97.29	-0.3%	-0.6%	+0.9%	+0.1%	-3.5%	-8.1%
Apr 16	Oppenheimer	Maintains	Outperform → Outperform	—	$97.55	$97.29	-0.3%	-0.6%	+0.9%	+0.1%	-3.5%	-8.1%
Feb 18	Baird	Upgrade	Neutral → Outperform	—	$96.43	$99.02	+2.7%	+3.3%	+2.8%	+3.2%	-1.3%	+1.5%
Feb 18	Oppenheimer	Maintains	Outperform → Outperform	—	$96.43	$99.02	+2.7%	+3.3%	+2.8%	+3.2%	-1.3%	+1.5%
Feb 17	Guggenheim	Downgrade	Buy → Neutral	—	$89.36	$98.89	+10.7%	+7.9%	+11.4%	+10.9%	+11.4%	+6.5%
Feb 13	Guggenheim	Downgrade	Buy → Neutral	—	$95.74	$93.32	-2.5%	-6.7%	+0.7%	+4.0%	+3.5%	+4.0%
Jan 27	Oppenheimer	Maintains	Outperform → Outperform	—	$98.38	$98.60	+0.2%	+0.6%	+0.8%	+1.8%	+0.7%	+2.1%
Jan 5	Johnson Rice	Maintains	Accumulate → Buy	—	$94.47	$94.80	+0.3%	+2.4%	+3.4%	+2.9%	+4.2%	+5.1%
Nov 4	Argus	Downgrade	Buy → Hold	—	$106.81	$104.50	-2.2%	-0.2%	+0.3%	-0.8%	-1.4%	-5.5%
Oct 31	Baird	Downgrade	Outperform → Neutral	—	$108.99	$111.70	+2.5%	-7.9%	-2.0%	-2.2%	-1.7%	-2.8%
Oct 16	JP Morgan	Maintains	Overweight → Overweight	—	$133.72	$134.77	+0.8%	+0.4%	-1.8%	+0.2%	-0.0%	-1.0%
Oct 7	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$125.94	$127.90	+1.6%	+0.5%	+1.3%	+0.5%	-3.0%	+1.9%
Jul 31	JP Morgan	Upgrade	Neutral → Overweight	—	$138.42	$130.71	-5.6%	-10.0%	-11.0%	-9.2%	-10.6%	-9.5%
Jul 22	Roth Capital	Maintains	Buy → Buy	—	$136.63	$137.09	+0.3%	-1.3%	-0.8%	-1.9%	-0.5%	-0.2%
Jul 22	JP Morgan	Maintains	Neutral → Neutral	—	$136.63	$137.09	+0.3%	-1.3%	-0.8%	-1.9%	-0.5%	-0.2%
Jul 14	Guggenheim	Maintains	Buy → Buy	—	$134.54	$135.18	+0.5%	+0.6%	+0.8%	+1.2%	+1.5%	+1.4%
May 5	Piper Sandler	Maintains	Neutral → Neutral	—	$108.23	$107.30	-0.9%	-0.6%	-1.4%	-1.8%	-0.3%	+0.3%
Apr 17	Guggenheim	Maintains	Buy → Buy	—	$101.65	$101.56	-0.1%	+1.6%	-0.2%	+2.4%	+3.7%	+7.4%
Feb 27	Piper Sandler	Maintains	Neutral → Neutral	—	$107.72	$107.95	+0.2%	-0.8%	+1.1%	-1.1%	-1.8%	-0.7%
Feb 27	Guggenheim	Maintains	Buy → Buy	—	$107.72	$107.95	+0.2%	-0.8%	+1.1%	-1.1%	-1.8%	-0.7%
Feb 26	Canaccord Genuity	Maintains	Buy → Buy	—	$101.81	$104.99	+3.1%	+5.8%	+5.0%	+7.0%	+4.6%	+3.9%
Feb 26	Oppenheimer	Maintains	Outperform → Outperform	—	$101.81	$104.99	+3.1%	+5.8%	+5.0%	+7.0%	+4.6%	+3.9%
Nov 6	Guggenheim	Maintains	Buy → Buy	—	$117.68	$122.56	+4.1%	+3.8%	+4.5%	+5.1%	+5.8%	+3.0%
Nov 1	Roth MKM	Maintains	Buy → Buy	—	$111.76	$112.91	+1.0%	+0.0%	+2.9%	+5.3%	+9.3%	+10.0%
Nov 1	Baird	Maintains	Outperform → Outperform	—	$111.76	$112.91	+1.0%	+0.0%	+2.9%	+5.3%	+9.3%	+10.0%
Nov 1	Oppenheimer	Maintains	Outperform → Outperform	—	$111.76	$112.91	+1.0%	+0.0%	+2.9%	+5.3%	+9.3%	+10.0%
Nov 1	Piper Sandler	Maintains	Neutral → Neutral	—	$111.76	$112.91	+1.0%	+0.0%	+2.9%	+5.3%	+9.3%	+10.0%
Nov 1	TD Cowen	Maintains	Buy → Buy	—	$111.76	$112.91	+1.0%	+0.0%	+2.9%	+5.3%	+9.3%	+10.0%
Aug 21	Roth MKM	Maintains	Buy → Buy	—	$97.15	$97.69	+0.6%	+2.4%	+3.1%	+5.0%	+4.7%	+4.7%
Aug 5	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$101.15	$96.72	-4.4%	-3.7%	-3.3%	-5.9%	-2.4%	-2.7%
Aug 2	Roth MKM	Maintains	Buy → Buy	—	$108.09	$103.85	-3.9%	-6.4%	-9.9%	-9.5%	-12.0%	-8.7%
Aug 2	Baird	Maintains	Outperform → Outperform	—	$108.09	$103.85	-3.9%	-6.4%	-9.9%	-9.5%	-12.0%	-8.7%
Jul 22	Piper Sandler	Maintains	Neutral → Neutral	—	$101.65	$102.16	+0.5%	+2.5%	+5.3%	+0.4%	-0.5%	+1.9%
Jul 17	Oppenheimer	Maintains	Outperform → Outperform	—	$107.43	$107.43	+0.0%	-4.2%	-4.6%	-5.4%	-3.0%	-0.4%
Jul 16	Roth MKM	Maintains	Buy → Buy	—	$105.18	$107.42	+2.1%	+2.1%	-2.1%	-2.5%	-3.4%	-0.9%
Jul 16	JP Morgan	Maintains	Neutral → Neutral	—	$105.18	$107.42	+2.1%	+2.1%	-2.1%	-2.5%	-3.4%	-0.9%
Jul 11	Guggenheim	Upgrade	Neutral → Buy	—	$100.00	$104.40	+4.4%	+3.4%	+4.6%	+5.2%	+7.4%	+2.9%
Jun 20	Canaccord Genuity	Maintains	Buy → Buy	—	$102.86	$102.35	-0.5%	-4.3%	-3.6%	-4.1%	-5.4%	-4.9%
May 21	Piper Sandler	Downgrade	Overweight → Neutral	—	$109.64	$107.10	-2.3%	-2.4%	-1.7%	-2.3%	-0.1%	+0.4%
May 6	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$107.01	$107.43	+0.4%	+0.3%	+1.2%	+1.9%	+1.4%	+0.3%
May 3	Canaccord Genuity	Maintains	Buy → Buy	—	$99.82	$102.55	+2.7%	+7.2%	+7.6%	+8.4%	+9.3%	+8.7%
May 3	TD Cowen	Maintains	Buy → Buy	—	$99.82	$102.55	+2.7%	+7.2%	+7.6%	+8.4%	+9.3%	+8.7%
May 3	Roth MKM	Maintains	Buy → Buy	—	$99.82	$102.55	+2.7%	+7.2%	+7.6%	+8.4%	+9.3%	+8.7%
May 3	Piper Sandler	Maintains	Overweight → Overweight	—	$99.82	$102.55	+2.7%	+7.2%	+7.6%	+8.4%	+9.3%	+8.7%
May 3	Oppenheimer	Maintains	Outperform → Outperform	—	$99.82	$102.55	+2.7%	+7.2%	+7.6%	+8.4%	+9.3%	+8.7%
Apr 23	Roth MKM	Maintains	Buy → Buy	—	$91.46	$91.77	+0.3%	+3.7%	+3.2%	+3.2%	+4.7%	+3.8%
Apr 11	Piper Sandler	Maintains	Overweight → Overweight	—	$90.49	$90.78	+0.3%	+1.9%	+1.0%	-0.6%	+0.3%	+0.0%

Recent Filings

8-K

Itron Inc -- 8-K Filing

Itron Inc disclosed a securities litigation matter under PSLRA protections while outlining its investigation and remediation efforts regarding an unspecified incident affecting the company.

Apr 24

8-K · 1.01 ! Medium

Itron Inc -- 8-K 1.01: Financing / Debt Agreement

Itron secured $700 million in convertible senior notes due 2032 through a private placement, providing debt financing while offering conversion equity upside to qualified institutional investors.

Feb 26

8-K

Itron Inc -- 8-K Filing

I cannot generate a meaningful investment analysis from this excerpt, as it contains only standard forward-looking statement disclaimers without substantive information about a material corporate event affecting Itron Inc.

Feb 17

Data updated apr 25, 2026 4:27pm · Source: massive.com